Literature DB >> 2876647

Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.

H G Pope, P E Keck, S L McElroy.   

Abstract

Neuroleptic malignant syndrome, a dangerous but little-known complication of antipsychotic drugs, is often assumed to be rare. To assess the frequency of the syndrome in a large psychiatric hospital, the authors first reviewed the literature and developed operational diagnostic criteria. Using these criteria to survey nearly 500 neuroleptic-treated patients admitted during a 1-year period, they found that seven (1.4%) had experienced definite or probable neuroleptic malignant syndrome. In several cases, including one fatal case, the diagnosis of neuroleptic malignant syndrome was not immediately considered. The authors conclude that neuroleptic malignant syndrome may be more common than previously thought and may be underdiagnosed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876647     DOI: 10.1176/ajp.143.10.1227

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  34 in total

1.  Neuroleptic malignant syndrome during multiple antipsychotic therapy.

Authors:  Margaret McDermott; Douglas L Noordsy; Marcy Traum
Journal:  Community Ment Health J       Date:  2011-10-30

2.  Risperidone-induced neuroleptic malignant syndrome in neurodegenerative disease: a case report.

Authors:  Daniel Johnson; Aby Z Philip; Dennis J Joseph; Roy Varghese
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

3.  Neuroleptic malignant syndrome in a developmentally handicapped adult: Risks associated with neuroleptic drug use.

Authors:  K E Fidler; P G Hodgetts
Journal:  Can Fam Physician       Date:  1992-06       Impact factor: 3.275

4.  Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism.

Authors:  T C Ryken; A N Merrell
Journal:  West J Med       Date:  1989-09

5.  Neuroleptic malignant syndrome in a patient with Wilson's disease.

Authors:  V Kontaxakis; C Stefanis; M Markidis; V Tserpe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

6.  Neuroleptic malignant syndrome: a complication of neuroleptics and cocaine abuse.

Authors:  M J Akpaffiong; P Ruiz
Journal:  Psychiatr Q       Date:  1991

7.  Neuroleptic malignant syndrome and lithium carbonate.

Authors:  S Fava; A C Galizia
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

8.  Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.

Authors:  J Kornhuber; M Weller
Journal:  J Neural Transm Gen Sect       Date:  1993

9.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

Review 10.  Antivertigo medications and drug-induced vertigo. A pharmacological review.

Authors:  O Rascol; T C Hain; C Brefel; M Benazet; M Clanet; J L Montastruc
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.